AMALKAN MEMBACA SURAH INI. MAKA KETIKA KITA MENINGAL AKAN DI DOAKAN 70 RIBU MALAIKAT
Sabtu, 04 Maret 2017

AMALKAN MEMBACA SURAH INI. MAKA KETIKA KITA MENINGAL AKAN DI DOAKAN 70 RIBU MALAIKAT

Mesothelioma is a form of cancer which occurs in thin membranes (called the mesothelium) lining the chest, lungs, abdomen and sometimes the heart. Although quite rare, mesothelioma symptoms strike more than 200 people each year in the United States. The majority of mesothelioma cases are directly linked to asbestos exposure. Because of the long latency period of mesothelioma, the average age of patients is between 50 and 70 years. Mesothelioma affects men most due to the high exposure of asbestos in industrial typed jobs. Mesothelioma symptoms include respiratory problems, shortness of breath, continual cough and pneumonia. Other mesothelioma symptoms include weight loss, abdominal problems and swelling. In some mesothelioma patients, the mesothelioma symptoms are quite muted, making it hard for mesothelioma doctors to diagnose. Mesothelioma doctors specialize in the study, research, and treatments of Mesothelioma cancers. Mesothelioma (or the cancer of the mesothelium) is a disease in which cells become abnormal and replicate without control. During Mesothelioma, these cells will invade and damage tissues and organs. Mesothelioma cancer cells can spread throughout the body causing death. Mesothelioma treatments and Mesothelioma clinical trials and tests There are many mesothelioma treatment options available. Treatments include surgery, radiation therapy and chemotherapy and the mesothelioma treatment depends on the patient’s age, general health and stage of the cancer. There has been much mesothelioma research conducted throughout the past two years to find new treatment methods. Click here to read more about mesothelioma treatment techniques. Through mesothelioma research, The National Cancer Institute has sponsored mesothelioma tests and clinical trials that are designed to find new treatment methods. Because of the increase in number of mesothelioma cases in the United States, both governments have increased funding for mesothelioma research. Mesothelioma research and clinical trials have been successful in developing new techniques to fight this cancer and the outlook for more advanced mesothelioma treatments is promising. Surgery is the most common treatment method for malignant mesothelioma. Tissues and linings affected by mesothelioma are removed by the doctor and may include the lung or even diaphragm. A second mesothelioma treatment method is radiation therapy through the use of high energy x-rays that kill the cancer cells. Radiation therapy can be outside or inside the body. A third mesothelioma treatment method is chemotherapy. Through pills or drugs through needles, chemotherapy drugs are used to kill cancer cells. A new mesothelioma treatment method is called intraoperative photodynamic therapy. In this treatment, light and drugs are used to kill cancer cells during surgery for early stages of mesothelioma in the chest. Although there are numerous treatments and drugs for mesothelioma, doctors are losing the battle against this deadly disease. Most mesothelioma treatments involve old techniques combined with different drug cocktails. However, in most cases, these mesothelioma treatments have many side effects including organ damage, nausea, increase in heart failure etc. The rush to find a more effective mesothelioma treatment or even cure is ongoing at numerous clinical labs across the nation. Let's hope that the mesothelioma treatments will one day erradicate mesothelioma cancer and asbestosis. With an abundance of information on the Internet, Mesothelioma Cancer and Asbestos ([http://www.mesothelioma-cancer-and-asbestos.com]) has consolidated the most important issues surrounding Mesothelioma, Mesothelioma doctors and symptoms, Mesothelioma treatment, Mesothelioma research and tests. At [http://www.mesothelioma-cancer-and-asbestos.com], the website contains useful resources on Mesothelioma lawyers and attorneys, as well as causes by asbestos exposure, asbestos removal, asbestos attorneys and lawsuits, and asbestos cancer. Patients stricken by Mesothelioma and their families require support and current information. Mesothelioma Online Resources hopes to educate and give hope to survivors and victims. Mesothelioma is such a harsh disease. Not only does it take years for symptoms to appear, but there are limited treatements and drugs that will prolong the lives of workers stricken with mesothelioma. In many cases, the death rate of mesothelioma is unfortunately very high. However, with increased funding in mesothelioma research through the government and private grants, the outlook for a mesothelioma cure is quite possible. In the meantime, mesothelioma support groups and local discussions provide the ongoing support for mesothelioma patients. Mesothelioma Cancer and Asbestos ([http://www.mesothelioma-cancer-and-asbestos.com])is your source for mesothelioma and asbestos information, treatments, clinical trials, attorneys, support groups and lawyers. About the website: Michael Kenneth is a successful Internet Publisher and has researched and written on many topics for [http://www.mesothelioma-cancer-and-asbestos.com] - your complete source for mesothelioma information, mesothelioma attorneys and lawyers, mesothelioma treatments and research, asbestos exposure and removal, asbestos attorneys and legislation as well as asbestos cancer.

Siraman Islam - Alhamdulillah… admin masih diberi kesempatan untuk berbagi
postingan di blog ini. Untuk kali ini renacananya admin bakal posting artikel mengenai “Jenazah yang di sholawati 70 ribu malaikat ” langsung ajah dibaca yah sobat !! 
 
ini hanya gambar i,lustrasi malaikat

Jenazah yang dishalawati 70 ribu malaikat

Kisah ini diriwayatkan oleh Anas bin Malik r.a.
Pada suatu pagi Rasulullah SAW bersama dengan sahabatnya Anas bin Malik r.a. melihat suatu keanehan. Bagaimana tidak, matahari terlihat begitu redup dan kurang bercahaya seperti biasanya.

Tak lama kemudian Rasulullah SAW dihampiri oleh Malaikat Jibril.

Lalu Rasulullah SAW bertanya kepada Malaikat Jibril : “Wahai Jibril, kenapa Matahari pagi ini terbit dalam keadaan redup? Padahal tidak mendung?”

“Ya Rasulullah, Matahari ini nampak redup karena terlalu banyak sayap para malaikat yang menghalanginya.” jawab Malaikat Jibril.

Rasulullah SAW bertanya lagi : “Wahai Jibril, berapa jumlah Malaikat yang menghalangi matahari
saat ini?”

“Ya Rasulullah, 70 ribu Malaikat.” jawab Malaikat Jibril.

Rasulullah SAW bertanya lagi : “Apa gerangan yang menjadikan Malaikat menutupi Matahari?”

Kemudian Malaikat Jibril menjawab : “Ketahuilah wahai Rasulullah, sesungguhnya Allah SWT telah mengutus 70 ribu Malaikat agar membacakan shalawat kepada salah satu umatmu.”

“Siapakah dia, wahai Jibril?” tanya Rasulullah SAW.

“Dialah Muawiyah…!!!”jawab Malaikat Jibril.

Rasulullah SAW bertanya lagi : “Apa yang telah dilakukan oleh Muawiyah sehingga saat ia meninggal mendapatkan kemuliaan yang sangat luar biasa ini?”

Malaikat Jibril menjawab : “Ketahuilah wahai Rasulullah, sesungguhnya Muawiyah itu semasa hidupnya banyak membaca Surat Al-Ikhlas di waktu malam, siang, pagi, waktu duduk, waktu berjalan, waktu berdiri, bahkan dalam setiap keadaan selalu membaca Surat Al-Ikhlas.”

Malaikat Jibril melanjutkan penuturannya : “Dari itulah Allah SWT mengutus sebanyak 70 ribu malaikat untuk membacakan shalawat kepada umatmu yang bernama Muawiyah tersebut.”

SubhanAllah..
Walhamdulillah..
Wala ilaha illallah..
Wallahu akbar.

Rasulullah SAW bersabda : ”Apakah seorang di antara kalian tidak mampu untuk membaca sepertiga Al-Qur’an dalam semalam?” Mereka menjawab, “Bagaimana mungkin kami bisa membaca sepertigai Al-Qur’an?” Lalu Nabi SAW bersabda, “Qul huwallahu ahad itu sebanding dengan sepertiga Al-Qur’an.” (H.R. Muslim no. 1922)

Thank to forum Eocommunity

Share on Facebook
Share on Twitter
Share on Google+

Related : AMALKAN MEMBACA SURAH INI. MAKA KETIKA KITA MENINGAL AKAN DI DOAKAN 70 RIBU MALAIKAT

0 komentar:

Posting Komentar

Catatan: Hanya anggota dari blog ini yang dapat mengirim komentar.